Associate Scientist, High-Throughput Experimentation Operations at Axsome Therapeutics Inc

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor’s degree in chemistry, Biochemistry, Chemical Engineering, or related scientific field
Hands-on laboratory experience in academic or industrial settings
Exceptional organizational skills and meticulous attention to detail
Strong time management abilities
Effective communication skills, both verbal and written
Ability to follow detailed protocols consistently
Comfortable with the repetitive nature of the work

Responsibilities

Locate and retrieve chemistry reagents from inventory for daily dispensing operations
Execute high-precision dispensing of approximately 300-400 solid samples weekly
Prepare solid samples for internal research teams and external collaboration partners
Receive, inventory, and organize chemistry reagents according to safety protocols
Maintain the reagent database by uploading and updating safety data sheets (SDS)
Maintain strict adherence to laboratory safety protocols, including proper use of PPE

Skills

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free